Business Description
Oncology Pharma Inc
NAICS : 551112
SIC : 2834
ISIN : US68235J2015
Description
Oncology Pharma Inc. is a U.S.-based company that, following the divestiture of its historical drug development operations, has functioned primarily as a shell or holding entity without active business operations. Its earlier activities centered on oncology-focused pharmaceutical development, including research into targeted cancer therapies and related drug delivery technologies. The company does not currently manufacture or sell products, generate recurring revenue, or serve a defined customer base, and it has no significant geographic markets. Its public listing has been associated with over-the-counter trading, and its activities have largely consisted of seeking financing, evaluating strategic alternatives, and pursuing potential merger or acquisition opportunities to establish a new operating business. As a result, its prospects depend on completing a transaction rather than on commercial operations.
Financial Strength
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 41.99 | |||||
9-Day RSI | 44.62 | |||||
14-Day RSI | 46.35 | |||||
3-1 Month Momentum % | 37.45 | |||||
6-1 Month Momentum % | 72.07 | |||||
12-1 Month Momentum % | 22900 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History |
|---|
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | N/A |
N/A
|
N/A
| |||
PE Ratio without NRI | N/A |
N/A
|
N/A
| |||
EV-to-EBIT | -27 | |||||
EV-to-EBITDA | -27 | |||||
EV-to-FCF | 2.25 | |||||
Earnings Yield (Greenblatt) % | -3.7 | |||||
FCF Yield % | 0.61 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:ONPH
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Oncology Pharma Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | - | ||
| Beta | -142.5815 | ||
| 3-Year Sharpe Ratio | 0.93 | ||
| 3-Year Sortino Ratio | 15.87 | ||
| Volatility % | 2952.42 | ||
| 14-Day RSI | 46.35 | ||
| 14-Day ATR ($) | 0.014902 | ||
| 20-Day SMA ($) | 0.056065 | ||
| 12-1 Month Momentum % | 22900 | ||
| 52-Week Range ($) | 0.0001 - 0.364 | ||
| Shares Outstanding (Mil) | 37.96 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Oncology Pharma Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Oncology Pharma Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| 0.01:1 Stock Split | 2020-10-09 | 0.78 (+27.87%) | ||
| 0.0001:1 Stock Split | 2016-01-04 | 100.00 (-50.00%) | ||
| 0.002:1 Stock Split | 2013-07-08 | 200,000.00 (-50.00%) | ||
| 0.25:1 Stock Split | 1999-08-26 | 4,436,000,000.00 (+0.00%) |
Show
Entries
Oncology Pharma Inc Frequently Asked Questions
What is Oncology Pharma Inc(ONPH)'s stock price today?
The current price of ONPH is $0.05. The 52 week high of ONPH is $0.36 and 52 week low is $0.00.
When is next earnings date of Oncology Pharma Inc(ONPH)?
The next earnings date of Oncology Pharma Inc(ONPH) is .
Does Oncology Pharma Inc(ONPH) pay dividends? If so, how much?
Oncology Pharma Inc(ONPH) does not pay dividend.
Press Release
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers